BACKGROUND AND PURPOSE: Endocannabinoids play an important role in modulating spinal nociceptive signalling, crucial for the development of pain. The cannabinoid CB1 receptor and the TRPV1 cation channel are both activated by the endocannabinoid anandamide, a product of biosynthesis from the endogenous lipid precursor N-arachidonoylphosphatidylethanolamine (20:4-NAPE). Here, we report CB1 receptor- and TRPV1-mediated effects of 20:4-NAPE on spinal synaptic transmission in control and inflammatory conditions. EXPERIMENTAL APPROACH: Spontaneous (sEPSCs) and dorsal root stimulation-evoked (eEPSCs) excitatory postsynaptic currents from superficial dorsal horn neurons in rat spinal cord slices were assessed. Peripheral inflammation was induced by carrageenan. Anandamide concentration was assessed by mass spectrometry. KEY RESULTS: Application of 20:4-NAPE increased anandamide concentration in vitro. 20:4-NAPE (20 μM) decreased sEPSCs frequency and eEPSCs amplitude in control and inflammatory conditions. The inhibitory effect of 20:4-NAPE was sensitive to CB1 receptor antagonist PF514273 (0.2 μM) in both conditions, but to the TRPV1 antagonist SB366791 (10 μM) only after inflammation. After inflammation, 20:4-NAPE increased sEPSCs frequency in the presence of PF514273 and this increase was blocked by SB366791. CONCLUSIONS AND IMPLICATIONS: While 20:4-NAPE treatment inhibited the excitatory synaptic transmission in both naive and inflammatory conditions, peripheral inflammation altered the underlying mechanisms. Our data indicate that 20:4-NAPE application induced mainly CB1 receptor-mediated inhibitory effects in naive animals while TRPV1-mediated mechanisms were also involved after inflammation. Increasing anandamide levels for analgesic purposes by applying substrate for its local synthesis may be more effective than systemic anandamide application or inhibition of its degradation. LINKED ARTICLES: This article is part of a themed section on Recent Advances in Targeting Ion Channels to Treat Chronic Pain. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.12/issuetoc.

Department of Functional Morphology Institute of Physiology The Czech Academy of Sciences Prague Czech Republic

Faculty of Science Charles University Prague Czech Republic

Section of Anaesthetics Pain Medicine and Intensive Care Department of Surgery and Cancer Imperial College London Faculty of Medicine Chelsea and Westminster Hospital London UK

Zobrazit více v PubMed

Ahluwalia J, Urban L, Bevan S, Nagy I (2003). Anandamide regulates neuropeptide release from capsaicin‐sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur J Neurosci 17: 2611–2618. PubMed

Ahluwalia J, Urban L, Capogna M, Bevan S, Nagy I (2000). Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience 100: 685–688. PubMed

Alexander SPH, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE PubMed PMC

Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE PubMed PMC

Alexander SPH, Catterall WA, Kelly E, Marrion N, Peters JA, Benson HE PubMed PMC

Alexander SPH, Peters JA, Kelly E, Marrion N, Benson HE, Faccenda E PubMed PMC

Alkaitis MS, Solorzano C, Landry RP, Piomelli D, DeLeo JA, Romero‐Sandoval EA (2010). Evidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative pain. PLoS One 5: e10891. PubMed PMC

Amaya F, Oh‐hashi K, Naruse Y, Iijima N, Ueda M, Shimosato G PubMed

Amaya F, Shimosato G, Kawasaki Y, Hashimoto S, Tanaka Y, Ji RR PubMed

Baccei ML, Bardoni R, Fitzgerald M (2003). Development of nociceptive synaptic inputs to the neonatal rat dorsal horn: glutamate release by capsaicin and menthol. J Physiol 549 (Pt 1): 231–242. PubMed PMC

Buczynski MW, Svensson CI, Dumlao DS, Fitzsimmons BL, Shim JH, Scherbart TJ PubMed PMC

Carrier EJ, Kearn CS, Barkmeier AJ, Breese NM, Yang W, Nithipatikom K PubMed

Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997). The capsaicin receptor: a heat‐activated ion channel in the pain pathway. Nature 389: 816–824. PubMed

Chemin J, Monteil A, Perez‐Reyes E, Nargeot J, Lory P (2001). Direct inhibition of T‐type calcium channels by the endogenous cannabinoid anandamide. EMBO J 20: 7033–7040. PubMed PMC

Costa B, Bettoni I, Petrosino S, Comelli F, Giagnoni G, Di Marzo V (2010). The dual fatty acid amide hydrolase/TRPV1 blocker, N‐arachidonoyl‐serotonin, relieves carrageenan‐induced inflammation and hyperalgesia in mice. Pharmacological Res 61: 537–546. PubMed

Curtis MJ, Bond RA, Spina D, Ahluwalia A, Alexander SP, Giembycz MA PubMed PMC

Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G PubMed

Dow RL, Carpino PA, Hadcock JR, Black SC, Iredale PA, DaSilva‐Jardine P PubMed

Farquhar‐Smith WP, Egertova M, Bradbury EJ, McMahon SB, Rice AS, Elphick MR (2000). Cannabinoid CB(1) receptor expression in rat spinal cord. Mol Cell Neurosci 15: 510–521. PubMed

Gunthorpe MJ, Rami HK, Jerman JC, Smart D, Gill CH, Soffin EM PubMed

Guo A, Vulchanova L, Wang J, Li X, Elde R (1999). Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur J Neurosci 11: 946–958. PubMed

Hegyi Z, Hollo K, Kis G, Mackie K, Antal M (2012). Differential distribution of diacylglycerol lipase‐alpha and N‐acylphosphatidylethanolamine‐specific phospholipase d immunoreactivity in the superficial spinal dorsal horn of rats. Glia 60: 1316–1329. PubMed PMC

Kanai Y, Nakazato E, Fujiuchi A, Hara T, Imai A (2005). Involvement of an increased spinal TRPV1 sensitization through its up‐regulation in mechanical allodynia of CCI rats. Neuropharmacology 49: 977–984. PubMed

Katona I, Freund TF (2008). Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 14: 923–930. PubMed

Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577–1579. PubMed PMC

Kim HI, Kim TH, Shin YK, Lee CS, Park M, Song JH (2005). Anandamide suppression of Na+ currents in rat dorsal root ganglion neurons. Brain Res 1062: 39–47. PubMed

Kim YH, Back SK, Davies AJ, Jeong H, Jo HJ, Chung G PubMed

Kwon SG, Roh DH, Yoon SY, Moon JY, Choi SR, Choi HS PubMed

Lappin SC, Randall AD, Gunthorpe MJ, Morisset V (2006). TRPV1 antagonist, SB‐366791, inhibits glutamatergic synaptic transmission in rat spinal dorsal horn following peripheral inflammation. Eur J Pharmacol 540: 73–81. PubMed

Lever IJ, Robinson M, Cibelli M, Paule C, Santha P, Yee L PubMed PMC

Luo H, Cheng J, Han JS, Wan Y (2004). Change of vanilloid receptor 1 expression in dorsal root ganglion and spinal dorsal horn during inflammatory nociception induced by complete Freund's adjuvant in rats. Neuroreport 15: 655–658. PubMed

Malek N, Kucharczyk M, Starowicz K (2014). Alterations in the anandamide metabolism in the development of neuropathic pain. Biomed Res Int 2014: 686908. PubMed PMC

Mallet C, Dubray C, Duale C (2016). FAAH inhibitors in the limelight, but regrettably. Int J Clin Pharmacol Ther 54: 498–501. PubMed PMC

McGrath JC, Lilley E (2015). Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol 172: 3189–3193. PubMed PMC

Morisset V, Ahluwalia J, Nagy I, Urban L (2001). Possible mechanisms of cannabinoid‐induced antinociception in the spinal cord. Eur J Pharmacol 429: 93–100. PubMed

Morisset V, Urban L (2001). Cannabinoid‐induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord. J Neurophysiol 86: 40–48. PubMed

Nagy I, Friston D, Valente JS, Torres Perez JV, Andreou AP (2014). Pharmacology of the capsaicin receptor, transient receptor potential vanilloid type‐1 ion channel. Prog Drug Res 68: 39–76. PubMed

Nyilas R, Gregg LC, Mackie K, Watanabe M, Zimmer A, Hohmann AG PubMed PMC

Okura D, Horishita T, Ueno S, Yanagihara N, Sudo Y, Uezono Y PubMed

O'Sullivan SE (2007). Cannabinoids go nuclear: evidence for activation of peroxisome proliferator‐activated receptors. Br J Pharmacol 152: 576–582. PubMed PMC

Park CK, Lu N, Xu ZZ, Liu T, Serhan CN, Ji RR (2011). Resolving TRPV1‐ and TNF‐alpha‐mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. J Neurosci 31: 15072–15085. PubMed PMC

Pernia‐Andrade AJ, Kato A, Witschi R, Nyilas R, Katona I, Freund TF PubMed PMC

Ren K, Dubner R (1999). Inflammatory Models of Pain and Hyperalgesia. ILAR J 40: 111–118. PubMed

Richardson JD, Kilo S, Hargreaves KM (1998). Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 75: 111–119. PubMed

Snider NT, Walker VJ, Hollenberg PF (2010). Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications. Pharmacol Rev 62: 136–154. PubMed PMC

Sousa‐Valente J, Andreou AP, Urban L, Nagy I (2014a). Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics. Br J Pharmacol 171: 2508–2527. PubMed PMC

Sousa‐Valente J, Varga A, Ananthan K, Khajuria A, Nagy I (2014b). Anandamide in primary sensory neurons: too much of a good thing? Eur J Neurosci 39: 409–418. PubMed

Sousa‐Valente J, Varga V, Torres Perez JVT, Jenes A, Wahba J, Mackie K PubMed

Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SPH PubMed PMC

Spicarova D, Adamek P, Kalynovska N, Mrozkova P, Palecek J (2014a). TRPV1 receptor inhibition decreases CCL2‐induced hyperalgesia. Neuropharmacology 81: 75–84. PubMed

Spicarova D, Nerandzic V, Palecek J (2011). Modulation of spinal cord synaptic activity by tumor necrosis factor alpha in a model of peripheral neuropathy. J Neuroinflammation 8: 177. PubMed PMC

Spicarova D, Nerandzic V, Palecek J (2014b). Update on the role of spinal cord TRPV1 receptors in pain modulation. Physiol Res 63 (Suppl 1): S225–S236. PubMed

Spicarova D, Palecek J (2009). The role of the TRPV1 endogenous agonist N‐Oleoyldopamine in modulation of nociceptive signaling at the spinal cord level. J Neurophysiol 102: 234–243. PubMed

Spicarova D, Palecek J (2010). Modulation of AMPA excitatory postsynaptic currents in the spinal cord dorsal horn neurons by insulin. Neuroscience 166: 305–311. PubMed

van der Stelt M, Trevisani M, Vellani V, De Petrocellis L, Schiano Moriello A, Campi B PubMed PMC

Tognetto M, Amadesi S, Harrison S, Creminon C, Trevisani M, Carreras M PubMed PMC

Ueda N, Tsuboi K, Uyama T (2013). Metabolism of endocannabinoids and related N‐acylethanolamines: canonical and alternative pathways. FEBS J 280: 1874–1894. PubMed

Varga A, Jenes A, Marczylo TH, Sousa‐Valente J, Chen J, Austin J PubMed

Vellani V, Petrosino S, De Petrocellis L, Valenti M, Prandini M, Magherini PC PubMed

Veress G, Meszar Z, Muszil D, Avelino A, Matesz K, Mackie K PubMed PMC

Wang J, Okamoto Y, Morishita J, Tsuboi K, Miyatake A, Ueda N (2006). Functional analysis of the purified anandamide‐generating phospholipase D as a member of the metallo‐beta‐lactamase family. J Biol Chem 281: 12325–12335. PubMed

Wang J, Ueda N (2009). Biology of endocannabinoid synthesis system. Prostaglandins Other Lipid Mediat 89: 112–119. PubMed

Wu ZZ, Chen SR, Pan HL (2005). Transient receptor potential vanilloid type 1 activation down‐regulates voltage‐gated calcium channels through calcium‐dependent calcineurin in sensory neurons. J Biol Chem 280: 18142–18151. PubMed

Yang K, Kumamoto E, Furue H, Li YQ, Yoshimura M (1999). Action of capsaicin on dorsal root‐evoked synaptic transmission to substantia gelatinosa neurons in adult rat spinal cord slices. Brain Res 830: 268–273. PubMed

Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V PubMed

20:4-NAPE induced changes of mechanical sensitivity and DRG neurons excitability are concentration dependent and mediated via NAPE-PLD

Anandamide-Mediated Modulation of Nociceptive Transmission at the Spinal Cord Level

Inhibition of synaptic transmission by anandamide precursor 20:4-NAPE is mediated by TRPV1 receptors under inflammatory conditions

Hypersensitivity Induced by Intrathecal Bradykinin Administration Is Enhanced by N-oleoyldopamine (OLDA) and Prevented by TRPV1 Antagonist